Digital health / tele
Access, chronic care, triage, care navigation
Healthtech, care delivery, diagnostics, medtech, and wellness — longer cycles, proof bars, and how to raise credibly in India.
Healthcare investors in India span digital health, care delivery networks, diagnostics, medtech devices, pharma-adjacent software, and consumer wellness. Timelines are often longer than pure software. Clinical validation, provider adoption, trust, and regulation sit beside product and growth.
Investors ask who pays (patient, employer, insurer, hospital), whether outcomes or cost savings are real, and how you acquire providers or patients without unsustainable subsidies. Device and deep-science stories need stronger evidence packages; consumer wellness needs retention and brand clarity that survives fads.
A credible raise matches capital to milestones: clinical, regulatory, distribution, or unit-economics proofs. Do not hide the long cycle — show why this team can navigate hospitals, doctors, and compliance, and what this round specifically de-risks.
Timelines are often longer than pure software.
How this category usually shows up for Indian founders raising capital.
Pick the sub-sector narrative before you shortlist funds.
Access, chronic care, triage, care navigation
Clinics, specialty chains, home care
Labs, imaging, at-home testing workflows
Hardware + software with clinical proof
Retention-led products with real outcomes
Bring the ones that match your model.
Core healthcare truth
Adoption quality
Unit economics of care
Revenue reality
Engagement beyond signup
De-risk path
Relative emphasis in partner conversations — directional, not a formula.
Use this before outreach — not after the first rejection.
Overclaiming clinical efficacy early
Ignoring who pays until the last slide
Underestimating hospital sales cycles
Consumer growth tactics that break trust in care
Raising too little for a regulatory-heavy path
Be the 'Y Combinator of India' — provide initial capital plus committed follow-on to idea-stage startups, supporting them across their first three funding rounds before connecting them to large VCs for growth capital.
$250K – $3M77 Capital backs early-stage Indian startups at Pre-Seed and Seed stages, focusing on SaaS, B2B marketplaces, FinTech, and HealthTech through a syndicate model that brings together aligned capital and operator networks.
$75K – $100KDeepTech-focused VC backing startups with strong scientific and research foundations that can fundamentally transform industries and economies; invests and enables, leveraging Middle East and Europe relationships to help portfolio companies expand globally and raise larger follow-on rounds.
$241K – $602KBack India's next generation of growth-stage companies across sectors
$10M – $75MBuild an expansive, India-centric platform of investment opportunities — make direct investments in technology-driven businesses with large India-first market potential, while seeding and anchoring entrepreneurial fund managers as a prime LP to broaden access to the startup ecosystem and keep companies domiciled in India.
$150M – $450MPioneer impact investing in India's most underserved communities
$500K – $10MAbhinav Lal focuses on Pre-Seed, Seed opportunities across Health, operating as a Angel / Individual relevant to Indian founders.
Pre-SeedBack bold founders from idea to IPO; Fund VIII centres on AI (enterprise, services-as-software, vertical AI) and consumer (Bharat, India-native, aspirational brands).
$1M – $18Mah! Ventures democratizes startup investing in India by connecting early-stage founders with a curated, pan-India network of angel investors, backing ventures from Pre-Seed through Pre-Series A across sectors including SaaS, Consumer, FinTech, and HealthTech.
$361K – $602KIndia-focused healthcare and wellness fund investing exclusively in scalable companies with validated product-market fit, governance-aligned leadership and a clear pathway to institutional scale; sector specialisation plus long-term partnership capital.
$100K – $5MAll In Capital backs pre-seed and seed stage founders across all sectors, writing early conviction cheques of around $200,000 to help companies find their footing and scale.
$200KAnkit Nagori focuses on Pre-Seed, Seed opportunities across Consumer / D2C, Health, operating as a Angel / Individual relevant to Indian founders.
Pre-SeedInvest in businesses solving fundamental needs in India - food, health, energy and education
$500K – $4MAnthill Ventures backs early-stage Indian startups at Pre-Seed to Pre-Series A, focusing on founders building scalable businesses in Web3, Health Tech, Consumer Internet, CleanTech, and PropTech with strong product-market fit potential.
$100K – $1MBack scalable, innovative solutions to real-life problems across tech and consumer/D2C; an operator-investor who mentors founders on building and scaling, with a sharp eye on unit economics.
$50K – $500KApollo Connect / Apollo Hospitals Ventures focuses on Seed, Series A opportunities across Health, operating as a Corporate / CVC relevant to Indian founders.
$5M – $10MBack tech founders solving problems for the next 500 million Indians
$500K – $5MAscent Capital backs growth-stage Indian companies at Series B and beyond, focusing on businesses with proven models in Consumer, FinTech, Healthcare, Education, and Technology that are ready to scale meaningfully across Indian markets.
$10M – $50MAshvik Kapital backs early-stage Indian startups across D2C, FinTech, Logistics, and Health Tech, deploying syndicated capital from Pre-Seed through Series A to founders building scalable, consumer-facing or technology-driven businesses.
$100K – $1MAthera Venture Partners backs early-stage technology-driven companies in India, partnering with founders at Seed through Series A to help build category-defining businesses with strong unit economics and scalable models.
$500K – $6MPartner with global teams on a mission to solve the world's most important problems; founder-first, impact-oriented investing with gender-lens principles, prioritising defensible IP and scalable models.
Pre-seed to Series A cheques (early-stage)Axilor Ventures backs early-stage Indian startups across SaaS, Consumer, FinTech, HealthTech, and B2B through structured accelerator programs and direct capital, targeting pre-seed to pre-Series A founders ready to validate and scale.
$100K – $1MB Capital backs technology companies enabling digital transformation across enterprise, fintech, healthtech, and SaaS, with a focus on growth-stage businesses demonstrating clear scalability across emerging and developed markets.
$10M – $100MBangalore Bioinnovation Centre Angels / BBC focuses on Pre-Seed, Seed opportunities across Health, Deep Tech, operating as a Accelerator relevant to Indian founders.
$24K – $60K